文献速递乳房整形与再造

第四代硅胶乳房假体破裂相关的硅胶腋窝淋巴结病

Silicone Axillary Lymphadenopathy Associated With Rupture of Fourth-Generation Cohesive Silicone Breast Implants Following Breast Augmentation.
PubMed 文献 · Aesthet Surg J · 2026-01-01

该回顾性研究纳入260例因MRI和超声发现假体破裂而手术取出第四代硅胶假体的患者,共299个破裂假体侧。结果发现硅胶腋窝淋巴结病(SAL)常见,假体取出时假体年龄增长与SAL独立相关,包膜外破裂有适度独立关联,假体制造商间无显著差异。

要点

  • 第四代硅胶假体破裂患者中SAL常见,包膜外破裂者更易出现。
  • 假体取出时假体年龄增长是SAL的独立相关因素。
  • 不同制造商假体的SAL发生率无显著差异。

核心结论

  • 在因第四代光滑 cohesive 硅胶假体破裂而手术的患者中,SAL频繁出现。
  • 假体取出时假体年龄增长与SAL独立相关,包膜外破裂显示适度独立关联。

研究设计与样本

  • 回顾性综述纳入260例连续患者,均经非增强乳腺/腋窝MRI和超声识别至少一个破裂的cohesive硅胶假体并手术取出。
  • 以假体侧为分析单位,双侧破裂分别计数,共299个破裂假体侧。
  • 所有患者均为初次隆乳,使用Allergan或Mentor第四代cohesive假体且有假体记录。

主要发现

  • 299个破裂假体侧中,包膜内破裂占81.6%,包膜外破裂占18.4%。
  • SAL在包膜内和包膜外破裂中均可发生,但包膜外破裂更常见。
  • 假体取出时假体年龄增长与SAL呈强独立关联,包膜外破裂呈适度独立关联。
  • 不同假体制造商间SAL无显著差异。

临床怎么用

  • 对第四代硅胶假体隆乳患者进行咨询和评估时,应考虑假体年龄和破裂类型对SAL风险的影响。
  • 手术取出破裂假体时,应关注腋窝淋巴结情况。

局限性

  • 证据等级为4级(治疗性)。
  • 结论主要基于第四代cohesive假体,需进一步研究第五代高cohesive假体。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Silicone implant rupture is a common complication of breast augmentation, with silicone axillary lymphadenopathy (SAL) a recognized sequela. OBJECTIVES: To evaluate SAL associated with surgically confirmed rupture of fourth-generation cohesive silicone breast implants and correlate imaging with operative findings. METHODS: A retrospective review included 260 consecutive patients undergoing surgery for removal of one or more ruptured cohesive silicone implants identified by non-contrast breast/axillary MRI and ultrasound. The implant-side was the unit of analysis, with bilateral ruptures counted separately. Implant characteristics, including manufacturer, volume, rupture type, and implant age at explantation, were correlated with ipsilateral axillary findings. All patients had primary augmentation with Allergan plc (Irvine, CA) or Mentor Worldwide LLC (Irvine, CA) fourth-generation cohesive implants and available implant records. Operative findings confirmed implant type, size, rupture presence, and rupture characteristics. RESULTS: Among 260 patients, 299 ruptured implant-sides were identified, with imaging findings corroborated surgically. Intracapsular rupture accounted for 81.6% of ruptured implant-sides with 18.4% extracapsular ruptures. SAL occurred with both intracapsular and extracapsular rupture types but was more commonly seen with extracapsular rupture. Increasing implant age at explantation showed a strong independent association with SAL, while extracapsular rupture demonstrated a modest independent association. No significant differences in SAL were observed by implant manufacturers. CONCLUSIONS: SAL was frequently observed in patients undergoing surgical management of ruptured smooth, fourth-generation cohesive silicone implants. Increasing implant age at explantation was independently associated with SAL, while extracapsular rupture showed a modest independent association. These findings strongly influence patient counseling and surgical evaluation of aging fourth-generation silicone implants. Further study of newer fifth-generation highly cohesive implants is warranted. LEVEL OF EVIDENCE: 4 (THERAPEUTIC): For image description, please refer to the figure legend and surrounding text.

来源:Aesthet Surg J,查看原文。版权归原作者所有。

引用

  1. Bresnick SD. Silicone Axillary Lymphadenopathy Associated With Rupture of Fourth-Generation Cohesive Silicone Breast Implants Following Breast Augmentation. Aesthet Surg J. 2026. PMID: 41622622. doi:10.1093/asj/sjag024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。